0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cell-Free DNA (cfDNA) Testing Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-28X5997
Home | Market Reports | Science| Biological Sciences
Global Cell Free DNA cfDNA Testing Market Insights and Forecast to 2028
BUY CHAPTERS

Global Cell-Free DNA (cfDNA) Testing Market Research Report 2025

Code: QYRE-Auto-28X5997
Report
September 2025
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Cell-Free DNA (cfDNA) Testing Market

The global market for Cell-Free DNA (cfDNA) Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Cell-Free DNA are fragments of DNA which circulate in the blood fluid and can be utilized as valuable biomarkers. It is a new technology in which small quantity of liquid sample (saliva, urine, or blood) from the patient is collected to examine the freely flowing DNA. Cell-Free DNA (cfDNA) is a noninvasive screening test used to help detect graft rejection, identify mutations in cancer patients and detect various chromosomal abnormalities in the fetus, to know the gender of the fetus. The discovery of cfDNA has opened up to new potentials in the field of oncology, gynecology, transplantation and infectious diseases.
Increased incidences of diseases like chromosomal abnormalities due to increasing maternal age, changing lifestyle, unhealthy diet habits and rising prevalence of cancer, also in addition to it increasing healthcare expenditure, and rising healthcare awareness are the reasons driving the cell-free DNA market.
This report aims to provide a comprehensive presentation of the global market for Cell-Free DNA (cfDNA) Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell-Free DNA (cfDNA) Testing.
The Cell-Free DNA (cfDNA) Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cell-Free DNA (cfDNA) Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell-Free DNA (cfDNA) Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Cell-Free DNA (cfDNA) Testing Market Report

Report Metric Details
Report Name Cell-Free DNA (cfDNA) Testing Market
Segment by Type
  • Donor-Derived Cell-Free DNA (DdcfDNA)
  • Circulating Cell-Free Tumor DNA (CtDNA)
  • Cell-Free Fetal DNA (NIPT)
Segment by Application
  • Hospital
  • Ambulatory Surgical Centers
  • Cancer Research Institutes
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Agilent Technology, Allenex, Biocept, Biodesix, CareDx, Guardant Health, Illumania, Invited, Natera, Quest Diagnostics, Roche Holdings, Sequenom, Trovagene
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Cell-Free DNA (cfDNA) Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cell-Free DNA (cfDNA) Testing Market report?

Ans: The main players in the Cell-Free DNA (cfDNA) Testing Market are Agilent Technology, Allenex, Biocept, Biodesix, CareDx, Guardant Health, Illumania, Invited, Natera, Quest Diagnostics, Roche Holdings, Sequenom, Trovagene

What are the Application segmentation covered in the Cell-Free DNA (cfDNA) Testing Market report?

Ans: The Applications covered in the Cell-Free DNA (cfDNA) Testing Market report are Hospital, Ambulatory Surgical Centers, Cancer Research Institutes

What are the Type segmentation covered in the Cell-Free DNA (cfDNA) Testing Market report?

Ans: The Types covered in the Cell-Free DNA (cfDNA) Testing Market report are Donor-Derived Cell-Free DNA (DdcfDNA), Circulating Cell-Free Tumor DNA (CtDNA), Cell-Free Fetal DNA (NIPT)

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell-Free DNA (cfDNA) Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Donor-Derived Cell-Free DNA (DdcfDNA)
1.2.3 Circulating Cell-Free Tumor DNA (CtDNA)
1.2.4 Cell-Free Fetal DNA (NIPT)
1.3 Market by Application
1.3.1 Global Cell-Free DNA (cfDNA) Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Ambulatory Surgical Centers
1.3.4 Cancer Research Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell-Free DNA (cfDNA) Testing Market Perspective (2020-2031)
2.2 Global Cell-Free DNA (cfDNA) Testing Growth Trends by Region
2.2.1 Global Cell-Free DNA (cfDNA) Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cell-Free DNA (cfDNA) Testing Historic Market Size by Region (2020-2025)
2.2.3 Cell-Free DNA (cfDNA) Testing Forecasted Market Size by Region (2026-2031)
2.3 Cell-Free DNA (cfDNA) Testing Market Dynamics
2.3.1 Cell-Free DNA (cfDNA) Testing Industry Trends
2.3.2 Cell-Free DNA (cfDNA) Testing Market Drivers
2.3.3 Cell-Free DNA (cfDNA) Testing Market Challenges
2.3.4 Cell-Free DNA (cfDNA) Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell-Free DNA (cfDNA) Testing Players by Revenue
3.1.1 Global Top Cell-Free DNA (cfDNA) Testing Players by Revenue (2020-2025)
3.1.2 Global Cell-Free DNA (cfDNA) Testing Revenue Market Share by Players (2020-2025)
3.2 Global Cell-Free DNA (cfDNA) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cell-Free DNA (cfDNA) Testing Revenue
3.4 Global Cell-Free DNA (cfDNA) Testing Market Concentration Ratio
3.4.1 Global Cell-Free DNA (cfDNA) Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell-Free DNA (cfDNA) Testing Revenue in 2024
3.5 Global Key Players of Cell-Free DNA (cfDNA) Testing Head office and Area Served
3.6 Global Key Players of Cell-Free DNA (cfDNA) Testing, Product and Application
3.7 Global Key Players of Cell-Free DNA (cfDNA) Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell-Free DNA (cfDNA) Testing Breakdown Data by Type
4.1 Global Cell-Free DNA (cfDNA) Testing Historic Market Size by Type (2020-2025)
4.2 Global Cell-Free DNA (cfDNA) Testing Forecasted Market Size by Type (2026-2031)
5 Cell-Free DNA (cfDNA) Testing Breakdown Data by Application
5.1 Global Cell-Free DNA (cfDNA) Testing Historic Market Size by Application (2020-2025)
5.2 Global Cell-Free DNA (cfDNA) Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cell-Free DNA (cfDNA) Testing Market Size (2020-2031)
6.2 North America Cell-Free DNA (cfDNA) Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cell-Free DNA (cfDNA) Testing Market Size by Country (2020-2025)
6.4 North America Cell-Free DNA (cfDNA) Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell-Free DNA (cfDNA) Testing Market Size (2020-2031)
7.2 Europe Cell-Free DNA (cfDNA) Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cell-Free DNA (cfDNA) Testing Market Size by Country (2020-2025)
7.4 Europe Cell-Free DNA (cfDNA) Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size (2020-2031)
8.2 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell-Free DNA (cfDNA) Testing Market Size (2020-2031)
9.2 Latin America Cell-Free DNA (cfDNA) Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cell-Free DNA (cfDNA) Testing Market Size by Country (2020-2025)
9.4 Latin America Cell-Free DNA (cfDNA) Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size (2020-2031)
10.2 Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Agilent Technology
11.1.1 Agilent Technology Company Details
11.1.2 Agilent Technology Business Overview
11.1.3 Agilent Technology Cell-Free DNA (cfDNA) Testing Introduction
11.1.4 Agilent Technology Revenue in Cell-Free DNA (cfDNA) Testing Business (2020-2025)
11.1.5 Agilent Technology Recent Development
11.2 Allenex
11.2.1 Allenex Company Details
11.2.2 Allenex Business Overview
11.2.3 Allenex Cell-Free DNA (cfDNA) Testing Introduction
11.2.4 Allenex Revenue in Cell-Free DNA (cfDNA) Testing Business (2020-2025)
11.2.5 Allenex Recent Development
11.3 Biocept
11.3.1 Biocept Company Details
11.3.2 Biocept Business Overview
11.3.3 Biocept Cell-Free DNA (cfDNA) Testing Introduction
11.3.4 Biocept Revenue in Cell-Free DNA (cfDNA) Testing Business (2020-2025)
11.3.5 Biocept Recent Development
11.4 Biodesix
11.4.1 Biodesix Company Details
11.4.2 Biodesix Business Overview
11.4.3 Biodesix Cell-Free DNA (cfDNA) Testing Introduction
11.4.4 Biodesix Revenue in Cell-Free DNA (cfDNA) Testing Business (2020-2025)
11.4.5 Biodesix Recent Development
11.5 CareDx
11.5.1 CareDx Company Details
11.5.2 CareDx Business Overview
11.5.3 CareDx Cell-Free DNA (cfDNA) Testing Introduction
11.5.4 CareDx Revenue in Cell-Free DNA (cfDNA) Testing Business (2020-2025)
11.5.5 CareDx Recent Development
11.6 Guardant Health
11.6.1 Guardant Health Company Details
11.6.2 Guardant Health Business Overview
11.6.3 Guardant Health Cell-Free DNA (cfDNA) Testing Introduction
11.6.4 Guardant Health Revenue in Cell-Free DNA (cfDNA) Testing Business (2020-2025)
11.6.5 Guardant Health Recent Development
11.7 Illumania
11.7.1 Illumania Company Details
11.7.2 Illumania Business Overview
11.7.3 Illumania Cell-Free DNA (cfDNA) Testing Introduction
11.7.4 Illumania Revenue in Cell-Free DNA (cfDNA) Testing Business (2020-2025)
11.7.5 Illumania Recent Development
11.8 Invited
11.8.1 Invited Company Details
11.8.2 Invited Business Overview
11.8.3 Invited Cell-Free DNA (cfDNA) Testing Introduction
11.8.4 Invited Revenue in Cell-Free DNA (cfDNA) Testing Business (2020-2025)
11.8.5 Invited Recent Development
11.9 Natera
11.9.1 Natera Company Details
11.9.2 Natera Business Overview
11.9.3 Natera Cell-Free DNA (cfDNA) Testing Introduction
11.9.4 Natera Revenue in Cell-Free DNA (cfDNA) Testing Business (2020-2025)
11.9.5 Natera Recent Development
11.10 Quest Diagnostics
11.10.1 Quest Diagnostics Company Details
11.10.2 Quest Diagnostics Business Overview
11.10.3 Quest Diagnostics Cell-Free DNA (cfDNA) Testing Introduction
11.10.4 Quest Diagnostics Revenue in Cell-Free DNA (cfDNA) Testing Business (2020-2025)
11.10.5 Quest Diagnostics Recent Development
11.11 Roche Holdings
11.11.1 Roche Holdings Company Details
11.11.2 Roche Holdings Business Overview
11.11.3 Roche Holdings Cell-Free DNA (cfDNA) Testing Introduction
11.11.4 Roche Holdings Revenue in Cell-Free DNA (cfDNA) Testing Business (2020-2025)
11.11.5 Roche Holdings Recent Development
11.12 Sequenom
11.12.1 Sequenom Company Details
11.12.2 Sequenom Business Overview
11.12.3 Sequenom Cell-Free DNA (cfDNA) Testing Introduction
11.12.4 Sequenom Revenue in Cell-Free DNA (cfDNA) Testing Business (2020-2025)
11.12.5 Sequenom Recent Development
11.13 Trovagene
11.13.1 Trovagene Company Details
11.13.2 Trovagene Business Overview
11.13.3 Trovagene Cell-Free DNA (cfDNA) Testing Introduction
11.13.4 Trovagene Revenue in Cell-Free DNA (cfDNA) Testing Business (2020-2025)
11.13.5 Trovagene Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Cell-Free DNA (cfDNA) Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Donor-Derived Cell-Free DNA (DdcfDNA)
 Table 3. Key Players of Circulating Cell-Free Tumor DNA (CtDNA)
 Table 4. Key Players of Cell-Free Fetal DNA (NIPT)
 Table 5. Global Cell-Free DNA (cfDNA) Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Cell-Free DNA (cfDNA) Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Cell-Free DNA (cfDNA) Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Cell-Free DNA (cfDNA) Testing Market Share by Region (2020-2025)
 Table 9. Global Cell-Free DNA (cfDNA) Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Cell-Free DNA (cfDNA) Testing Market Share by Region (2026-2031)
 Table 11. Cell-Free DNA (cfDNA) Testing Market Trends
 Table 12. Cell-Free DNA (cfDNA) Testing Market Drivers
 Table 13. Cell-Free DNA (cfDNA) Testing Market Challenges
 Table 14. Cell-Free DNA (cfDNA) Testing Market Restraints
 Table 15. Global Cell-Free DNA (cfDNA) Testing Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Cell-Free DNA (cfDNA) Testing Market Share by Players (2020-2025)
 Table 17. Global Top Cell-Free DNA (cfDNA) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-Free DNA (cfDNA) Testing as of 2024)
 Table 18. Ranking of Global Top Cell-Free DNA (cfDNA) Testing Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Cell-Free DNA (cfDNA) Testing Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Cell-Free DNA (cfDNA) Testing, Headquarters and Area Served
 Table 21. Global Key Players of Cell-Free DNA (cfDNA) Testing, Product and Application
 Table 22. Global Key Players of Cell-Free DNA (cfDNA) Testing, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Cell-Free DNA (cfDNA) Testing Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Cell-Free DNA (cfDNA) Testing Revenue Market Share by Type (2020-2025)
 Table 26. Global Cell-Free DNA (cfDNA) Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Cell-Free DNA (cfDNA) Testing Revenue Market Share by Type (2026-2031)
 Table 28. Global Cell-Free DNA (cfDNA) Testing Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Cell-Free DNA (cfDNA) Testing Revenue Market Share by Application (2020-2025)
 Table 30. Global Cell-Free DNA (cfDNA) Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Cell-Free DNA (cfDNA) Testing Revenue Market Share by Application (2026-2031)
 Table 32. North America Cell-Free DNA (cfDNA) Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Cell-Free DNA (cfDNA) Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Cell-Free DNA (cfDNA) Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Cell-Free DNA (cfDNA) Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Cell-Free DNA (cfDNA) Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Cell-Free DNA (cfDNA) Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Cell-Free DNA (cfDNA) Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Cell-Free DNA (cfDNA) Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Cell-Free DNA (cfDNA) Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Agilent Technology Company Details
 Table 48. Agilent Technology Business Overview
 Table 49. Agilent Technology Cell-Free DNA (cfDNA) Testing Product
 Table 50. Agilent Technology Revenue in Cell-Free DNA (cfDNA) Testing Business (2020-2025) & (US$ Million)
 Table 51. Agilent Technology Recent Development
 Table 52. Allenex Company Details
 Table 53. Allenex Business Overview
 Table 54. Allenex Cell-Free DNA (cfDNA) Testing Product
 Table 55. Allenex Revenue in Cell-Free DNA (cfDNA) Testing Business (2020-2025) & (US$ Million)
 Table 56. Allenex Recent Development
 Table 57. Biocept Company Details
 Table 58. Biocept Business Overview
 Table 59. Biocept Cell-Free DNA (cfDNA) Testing Product
 Table 60. Biocept Revenue in Cell-Free DNA (cfDNA) Testing Business (2020-2025) & (US$ Million)
 Table 61. Biocept Recent Development
 Table 62. Biodesix Company Details
 Table 63. Biodesix Business Overview
 Table 64. Biodesix Cell-Free DNA (cfDNA) Testing Product
 Table 65. Biodesix Revenue in Cell-Free DNA (cfDNA) Testing Business (2020-2025) & (US$ Million)
 Table 66. Biodesix Recent Development
 Table 67. CareDx Company Details
 Table 68. CareDx Business Overview
 Table 69. CareDx Cell-Free DNA (cfDNA) Testing Product
 Table 70. CareDx Revenue in Cell-Free DNA (cfDNA) Testing Business (2020-2025) & (US$ Million)
 Table 71. CareDx Recent Development
 Table 72. Guardant Health Company Details
 Table 73. Guardant Health Business Overview
 Table 74. Guardant Health Cell-Free DNA (cfDNA) Testing Product
 Table 75. Guardant Health Revenue in Cell-Free DNA (cfDNA) Testing Business (2020-2025) & (US$ Million)
 Table 76. Guardant Health Recent Development
 Table 77. Illumania Company Details
 Table 78. Illumania Business Overview
 Table 79. Illumania Cell-Free DNA (cfDNA) Testing Product
 Table 80. Illumania Revenue in Cell-Free DNA (cfDNA) Testing Business (2020-2025) & (US$ Million)
 Table 81. Illumania Recent Development
 Table 82. Invited Company Details
 Table 83. Invited Business Overview
 Table 84. Invited Cell-Free DNA (cfDNA) Testing Product
 Table 85. Invited Revenue in Cell-Free DNA (cfDNA) Testing Business (2020-2025) & (US$ Million)
 Table 86. Invited Recent Development
 Table 87. Natera Company Details
 Table 88. Natera Business Overview
 Table 89. Natera Cell-Free DNA (cfDNA) Testing Product
 Table 90. Natera Revenue in Cell-Free DNA (cfDNA) Testing Business (2020-2025) & (US$ Million)
 Table 91. Natera Recent Development
 Table 92. Quest Diagnostics Company Details
 Table 93. Quest Diagnostics Business Overview
 Table 94. Quest Diagnostics Cell-Free DNA (cfDNA) Testing Product
 Table 95. Quest Diagnostics Revenue in Cell-Free DNA (cfDNA) Testing Business (2020-2025) & (US$ Million)
 Table 96. Quest Diagnostics Recent Development
 Table 97. Roche Holdings Company Details
 Table 98. Roche Holdings Business Overview
 Table 99. Roche Holdings Cell-Free DNA (cfDNA) Testing Product
 Table 100. Roche Holdings Revenue in Cell-Free DNA (cfDNA) Testing Business (2020-2025) & (US$ Million)
 Table 101. Roche Holdings Recent Development
 Table 102. Sequenom Company Details
 Table 103. Sequenom Business Overview
 Table 104. Sequenom Cell-Free DNA (cfDNA) Testing Product
 Table 105. Sequenom Revenue in Cell-Free DNA (cfDNA) Testing Business (2020-2025) & (US$ Million)
 Table 106. Sequenom Recent Development
 Table 107. Trovagene Company Details
 Table 108. Trovagene Business Overview
 Table 109. Trovagene Cell-Free DNA (cfDNA) Testing Product
 Table 110. Trovagene Revenue in Cell-Free DNA (cfDNA) Testing Business (2020-2025) & (US$ Million)
 Table 111. Trovagene Recent Development
 Table 112. Research Programs/Design for This Report
 Table 113. Key Data Information from Secondary Sources
 Table 114. Key Data Information from Primary Sources
 Table 115. Authors List of This Report


List of Figures
 Figure 1. Cell-Free DNA (cfDNA) Testing Picture
 Figure 2. Global Cell-Free DNA (cfDNA) Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Cell-Free DNA (cfDNA) Testing Market Share by Type: 2024 VS 2031
 Figure 4. Donor-Derived Cell-Free DNA (DdcfDNA) Features
 Figure 5. Circulating Cell-Free Tumor DNA (CtDNA) Features
 Figure 6. Cell-Free Fetal DNA (NIPT) Features
 Figure 7. Global Cell-Free DNA (cfDNA) Testing Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Cell-Free DNA (cfDNA) Testing Market Share by Application: 2024 VS 2031
 Figure 9. Hospital Case Studies
 Figure 10. Ambulatory Surgical Centers Case Studies
 Figure 11. Cancer Research Institutes Case Studies
 Figure 12. Cell-Free DNA (cfDNA) Testing Report Years Considered
 Figure 13. Global Cell-Free DNA (cfDNA) Testing Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Cell-Free DNA (cfDNA) Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Cell-Free DNA (cfDNA) Testing Market Share by Region: 2024 VS 2031
 Figure 16. Global Cell-Free DNA (cfDNA) Testing Market Share by Players in 2024
 Figure 17. Global Top Cell-Free DNA (cfDNA) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-Free DNA (cfDNA) Testing as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Cell-Free DNA (cfDNA) Testing Revenue in 2024
 Figure 19. North America Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Cell-Free DNA (cfDNA) Testing Market Share by Country (2020-2031)
 Figure 21. United States Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Cell-Free DNA (cfDNA) Testing Market Share by Country (2020-2031)
 Figure 25. Germany Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Share by Region (2020-2031)
 Figure 33. China Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Cell-Free DNA (cfDNA) Testing Market Share by Country (2020-2031)
 Figure 41. Mexico Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Share by Country (2020-2031)
 Figure 45. Turkey Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Agilent Technology Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2020-2025)
 Figure 49. Allenex Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2020-2025)
 Figure 50. Biocept Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2020-2025)
 Figure 51. Biodesix Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2020-2025)
 Figure 52. CareDx Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2020-2025)
 Figure 53. Guardant Health Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2020-2025)
 Figure 54. Illumania Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2020-2025)
 Figure 55. Invited Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2020-2025)
 Figure 56. Natera Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2020-2025)
 Figure 57. Quest Diagnostics Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2020-2025)
 Figure 58. Roche Holdings Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2020-2025)
 Figure 59. Sequenom Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2020-2025)
 Figure 60. Trovagene Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2020-2025)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc